Search - tctmd.com

Displaying 161 - 180 of 231

Sort: Relevancy | Date

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Yael L. Maxwell

September 02, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

News Daily News

Unrecognized Obstructive Sleep Apnea Linked to CV Complications After Noncardiac Surgery

L.A. McKeown

May 14, 2019

News Daily News

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

L.A. McKeown

April 30, 2019

News Opinion Fellow Talk

Public Reporting and the Budding Interventional Cardiologist

Yashasvi Chugh, MD

March 28, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

Todd Neale

March 05, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

Breast Calcifications May Hold Important Clues for CV Risk Stratification

L.A. McKeown

February 22, 2019

Advertisement

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

TCTMD’s Top 10 Most Popular Stories for July 2019

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

New Clarity on Patients at High Risk for Bleeding After PCI

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Unrecognized Obstructive Sleep Apnea Linked to CV Complications After Noncardiac Surgery

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

Public Reporting and the Budding Interventional Cardiologist

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

Breast Calcifications May Hold Important Clues for CV Risk Stratification

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content